Formoterol protects against platelet-activating factor-induced effects in asthma.

@article{Gabrijelcic2004FormoterolPA,
  title={Formoterol protects against platelet-activating factor-induced effects in asthma.},
  author={J Gabrijelcic and Alejandro Casas and Roberto A Rabinovich and Josep Roca and Joan Albert Barber{\`a} and Kian Fan Chung and Robert 6 Rodriguez-Roisin},
  journal={The European respiratory journal},
  year={2004},
  volume={23 1},
  pages={71-5}
}
Platelet-activating factor (PAF) is an inflammatory mediator that provokes neutropaenia, bronchoconstriction and gas exchange defects due to exudation of bulk plasma within the airways. While the inhibitory effects of short-acting beta2-agonists on PAF-induced disturbances have been consistently shown, those of long-acting beta2-agonists are less convincing… CONTINUE READING